Tecan Group AG/€TECN
06:30
10:10
13:45
17:25
21:00
1D1W1MYTD1Y5YMAX
About Tecan Group AG
Tecan Group AG is a Swiss company specializing in laboratory instruments and solutions within the life sciences sector. The company offers a range of automated workflow and instrumentation solutions for laboratories involved in diagnostics, bio-pharmaceuticals, and forensics. Founded in 1980 and headquartered in Männedorf, Switzerland, Tecan operates globally, serving clients across various continents. The company's strategic positioning lies in its emphasis on automation and high-throughput systems, which cater to the growing demand for efficiency in laboratory settings. Tecan's products are characterized by their precision and adaptability, allowing for integration into diverse laboratory environments.
Ticker
€TECN
Sector
Primary listing
XGAT
Employees
3,000
Headquarters
Männedorf, Switzerland
Website
Tecan Group AG Metrics
BasicAdvanced
€2.1B
30.46
€5.35
0.93
€3.24
0.99%
Price and volume
Market cap
€2.1B
Beta
0.93
52-week high
€262.92
52-week low
€140.27
Average daily volume
27K
Dividend rate
€3.24
Financial strength
Current ratio
1.608
Quick ratio
1.144
Long term debt to equity
4.789
Total debt to equity
25.123
Dividend payout ratio (TTM)
60.24%
Interest coverage (TTM)
16.26%
Profitability
EBITDA (TTM)
112.885
Gross margin (TTM)
35.19%
Net profit margin (TTM)
6.96%
Operating margin (TTM)
7.38%
Effective tax rate (TTM)
13.73%
Revenue per employee (TTM)
€324,080
Management effectiveness
Return on assets (TTM)
2.06%
Return on equity (TTM)
4.70%
Valuation
Price to earnings (TTM)
30.461
Price to revenue (TTM)
2.119
Price to book
1.49
Price to tangible book (TTM)
1.49
Price to free cash flow (TTM)
14.335
Free cash flow yield (TTM)
6.98%
Free cash flow per share (TTM)
11.363
Dividend yield (TTM)
1.99%
Forward dividend yield
0.99%
Growth
Revenue change (TTM)
-9.34%
Earnings per share change (TTM)
-37.24%
3-year revenue growth (CAGR)
-5.57%
10-year revenue growth (CAGR)
7.81%
3-year earnings per share growth (CAGR)
-15.74%
10-year earnings per share growth (CAGR)
1.77%
3-year dividend per share growth (CAGR)
2.33%
10-year dividend per share growth (CAGR)
7.18%
Bulls say / Bears say
Tecan’s Q2 2025 order intake returned to growth in the mid-single digits, and the book-to-bill ratio for H1 climbed above 1, indicating recovering demand and an improving backlog (Reuters)
Tecan announced a CHF 120 million share buyback—amounting to 6% of share capital—demonstrating management’s confidence in long-term business prospects and the company’s robust financial position (Reuters)
Monica Manotas, who spent 24 years at Thermo Fisher Scientific, took over as CEO effective August 1, 2025, bringing deep life-sciences experience and leadership aimed at driving innovation and growth (Reuters)
H1 sales fell 5.9% in Swiss francs, highlighting continued pressure on revenue as demand remained soft in both Life Sciences and Partnering divisions, despite cost-cutting measures (Reuters)
Tecan’s EBIT margin dropped to a historic low of 5.3% in H1 2025, impacted by foreign exchange fluctuations, U.S. tariffs, and weak Life Sciences instrument sales (Reuters)
While Waters Corporation increased the lower end of its 2025 profit forecast thanks to strong biotech demand, Tecan’s guidance signals between a mid-single-digit sales decline and low-single-digit growth, with EBITDA falling short of consensus estimates and suggesting the risk of losing market share (Reuters, Reuters)
Data summarised monthly by Lightyear AI. Last updated on 5 Oct 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Tecan Group AG stock?
Tecan Group AG (TECN) has a market cap of €2.1B as of October 29, 2025.
What is the P/E ratio for Tecan Group AG stock?
The price to earnings (P/E) ratio for Tecan Group AG (TECN) stock is 30.46 as of October 29, 2025.
Does Tecan Group AG stock pay dividends?
Yes, the Tecan Group AG (TECN) stock pays dividends to shareholders. As of October 29, 2025, the dividend rate is €3.23685 and the yield is 0.99%. Tecan Group AG has a payout ratio of 60.24% on a trailing twelve-month basis.
When is the next Tecan Group AG dividend payment date?
The next Tecan Group AG (TECN) dividend payment date is unconfirmed.
What is the beta indicator for Tecan Group AG?
Tecan Group AG (TECN) has a beta rating of 0.93. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.